Search

Your search keyword '"Renieri, Alessandra"' showing total 1,377 results

Search Constraints

Start Over You searched for: Author "Renieri, Alessandra" Remove constraint Author: "Renieri, Alessandra"
1,377 results on '"Renieri, Alessandra"'

Search Results

101. Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals

102. ENIGMA CHEK2gether Project:A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

107. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing

108. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

109. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study

110. Phenotype and genotype of 87 patients with Mowat–Wilson syndrome and recommendations for care

112. An Example of Neuro-Glial Commitment and Differentiation of Muse Stem Cells Obtained from Patients with IQSEC2-Related Neural Disorder: A Possible New Cell-Based Disease Model

114. Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot

115. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

116. Corrigendum: Spondyloocular syndrome: A novel XYLT2 variant with description of the neonatal phenotype

117. Correction: The 2019 and 2021 International workshops on Alport syndrome

118. Correction: New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells

119. A Solve-RD ClinVar-based reanalysis of 1,522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

120. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor

121. Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19

122. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

123. Coffin–Siris and Nicolaides–Baraitser syndromes are a common well recognizable cause of intellectual disability

124. Positive predictive values and outcomes for uninformative cell‐free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study)

125. Digenic Alport Syndrome

126. Expanding the clinical spectrum associated with the PACS1 p.Arg203Trp mutational hot‐spot: Two additional Italian patients

127. Solving unsolved rare neurological diseases-a Solve-RD viewpoint

129. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

130. The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

132. Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity

133. CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD

134. Natural history of KBG syndrome in a large European cohort

135. Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome

138. A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis

139. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

141. Novel genes and sex differences in COVID-19 severity

142. Natural history of KBG syndrome in a large European cohort

143. Supplementary files of the article 'Novel genes and sex differences in COVID-19 severity' [Dataset]

144. Novel genes and sex differences in COVID-19 severity

145. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

146. An explainable model of host genetic interactions linked to COVID-19 severity

147. Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes

148. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

149. Guidelines for Genetic Testing and Management of Alport Syndrome

150. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

Catalog

Books, media, physical & digital resources